<i>APOE</i> genotype, cholesterol level, lipid-lowering treatment, and dementia

Abstract

This observational study provides further evidence that lipid-lowering agents are associated with decreased risk of dementia, whereas hyperlipidemia is associated with increased odds for non-Alzheimer-disease-type dementia. These effects appear to be independent of all major potential confounders.